Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04978688
What this trial is testing

Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants

Who this might be right for
Healthy
Myovant Sciences GmbH 48
Early research (Phase 1)Study completedNCT05028556
What this trial is testing

A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Metastatic or Locally Advanced Solid Tumors
Wuhan YZY Biopharma Co., Ltd. 50
Early research (Phase 1)Study completedNCT02914353
What this trial is testing

Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects

Who this might be right for
Arthroplasty, Replacement, Knee
eXIthera Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT05324137
What this trial is testing

CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
Keymed Biosciences Co.Ltd 88
Early research (Phase 1)Study completedNCT01176175
What this trial is testing

Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study

Who this might be right for
Infertility
Productos Científicos S. A. de C. V. 48
Large-scale testing (Phase 3)Study completedNCT01072149
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54
Early research (Phase 1)Looking for participantsNCT07800936
What this trial is testing

HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumors
Parr Biotechnology (Hebei) Co., Ltd. 44
Post-approval studies (Phase 4)Study completedNCT03774394
What this trial is testing

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

Who this might be right for
Chronic Kidney Disease (CKD)Type 2 Diabetes Mellitus (T2DM)Coronary Artery Disease (CAD)
University of Florida 61
Early research (Phase 1)Study completedNCT01208753
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 24
Early research (Phase 1)Study completedNCT03202875
What this trial is testing

Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Sanofi 30
Testing effectiveness (Phase 2)Study completedNCT04641299
What this trial is testing

AZD8233 in Participants With Dyslipidemia

Who this might be right for
Dyslipidaemia
AstraZeneca 119
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT01889667
What this trial is testing

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus Type 2
Oramed, Ltd. 30
Early research (Phase 1)Study completedNCT06204809
What this trial is testing

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 24
Early research (Phase 1)Study completedNCT02214693
What this trial is testing

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Who this might be right for
Renal Impairment
Dong-A ST Co., Ltd. 30
Early research (Phase 1)Study completedNCT02004587
What this trial is testing

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Who this might be right for
Hepatic Impairment
LG Life Sciences 28
Testing effectiveness (Phase 2)Study completedNCT00967707
What this trial is testing

Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain

Who this might be right for
Post-traumatic Neuropathic Pain
Uppsala University 30
Early research (Phase 1)Study completedNCT02306915
What this trial is testing

PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants

Who this might be right for
PharmacokineticsPharmacodynamics
Merckle GmbH 48
Not applicableUnknownNCT04083443
What this trial is testing

Model for PK/PD of Antimicrobials in Blood Stream Infection: Feasibility

Who this might be right for
Blood Stream Infections
University of Cologne 120
Early research (Phase 1)Study completedNCT04464733
What this trial is testing

Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects

Who this might be right for
Chronic Hepatitis b
Jiangsu HengRui Medicine Co., Ltd. 146
Next Page